BAK and BAX: Therapeutic Targets for Acute Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury
Biology · 31.12.2025 · 15 (1) · 81
DOI: 10.3390/biology15010081 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 31.12.2025. Verfasst von Zejun Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Key Technology Research on Chemical Raw Materials and Preparations of Guangdong Province, Department of Science and Technology of G…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Youth Fund Project, Guangdong Provincial Science and Technology Program Project, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Acute myocardial infarction (AMI) is a significant factor leading to the death of patients with coronary heart disease. Both AMI and reperfusion therapy after AMI cause myocardial cell death, which plays a significant role in heart failure. Following the restoration of blood flow during reperfusion, myocardial cells generate a large amount of oxygen free radicals, causing various forms of myocardial ischemia–reperfusion (IR) injury (IRI), ultimately leading to multiple types of myocardial cell death, among which apoptosis and necroptosis are the two major types. Given the extremely limited regenerative capacity of myocardium, inhibiting myocardial cell apoptosis and necroptosis is a key strategy for reducing mortality in patients with AMI. Both apoptosis and necroptosis are regulated by the BCL2 family of proteins, which were modulated by multiple signaling pathways, converging at BAK/BAX-mediated mitochondrial outer membrane permeabilization (MOMP), as well as mitochondrial inner membrane permeabilization (MIMP). BAK/BAX double knock out (DKO) mice showed reduced cell apoptosis, necroptosis, and infarct size in AMI animal models compared to wild type. This review describes the role of BCL2 family proteins in regulating apoptotic and necroptotic myocardial cell death during AMI and IR, explores the upstream pathways modulating apoptosis and necroptosis, and summarizes the recent advances in targeting BAK and/or BAX for cardiac protection. In addition, targeted delivery of BAK/BAX inhibitors to cardiomyocytes during AMI or myocardial IR has the potential to reduce myocardial cell death and therefore lower the mortality and enhance long-term prognosis for myocardial infarction patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Key Technology Research on Chemical Raw Materials and Preparations of Guangdong Province, Department of Science and Technology of Guangdong Province, People's Government of Guangdong Province, Guangzho…
- Institute of Pharmacology, GuangZhou BaiYunShan Pharmaceutical Holdings Co., Ltd., BaiYunShan Pharmaceutical General Factory, Guangzhou 510410, China.
- College of Life Sciences, University of Science and Technology of China, Hefei 230026, China.
- Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang 621000, China.
- Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
ORCID-Profile: Kaiqin Ye, Haiming Dai
Förderung
- National Natural Science Foundation of China Youth Fund Project
- Guangdong Provincial Science and Technology Program Project
- Guangdong Basic and Applied Basic Research Foundation
- Young Talent Support Project of Guangzhou Association for Science and Technology
Zitieren
APA
Xu, Z., Meng, F., Yang, H., Liu, Y., Ye, K., Qin, F., Liu, D., & Dai, H. (2025). BAK and BAX: Therapeutic Targets for Acute Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury. Biology, 15(1), 81. https://doi.org/10.3390/biology15010081
Vancouver
Xu Z, Meng F, Yang H, Liu Y, Ye K, Qin F, et al. BAK and BAX: Therapeutic Targets for Acute Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury. Biology. 2025;15(1):81. doi:10.3390/biology15010081
BibTeX
@article{Xu2025,
author = {Xu, Zejun and Meng, Fei and Yang, Hongjun and Liu, Yaling and Ye, Kaiqin and Qin, Fei and Liu, Dongyan and Dai, Haiming},
title = {BAK and BAX: Therapeutic Targets for Acute Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury},
journal = {Biology},
year = {2025},
volume = {15},
number = {1},
pages = {81},
doi = {10.3390/biology15010081}
}
EUVIMED